Solara Active Pharma Sciences Limited (BOM:890202)
308.70
+35.20 (12.87%)
At close: Apr 1, 2026
BOM:890202 Market Cap
BOM:890202 has a market cap or net worth of 32.99 billion as of October 7, 2026. Its market cap has increased by 11.19% in one year.
Market Cap
32.99B
Enterprise Value
39.35B
Revenue
14.31B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2018, BOM:890202's market cap has increased from 6.21B to 32.99B, an increase of 431.05%. That is a compound annual growth rate of 22.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 32.94B | 21.03% |
| Dec 31, 2025 | 27.21B | -16.57% |
| Dec 31, 2024 | 32.62B | 150.91% |
| Dec 29, 2023 | 13.00B | -16.05% |
| Dec 30, 2022 | 15.49B | -57.73% |
| Dec 31, 2021 | 36.63B | -14.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 280.87B |
| Shilpa Medicare | 209.75B |
| Suven Life Sciences | 87.41B |
| Symbiotec Pharmalab | 75.16B |
| IOL Chemicals and Pharmaceuticals | 60.35B |
| Gujarat Themis Biosyn | 48.55B |
| NGL Fine-Chem | 19.15B |
| Bajaj HealthCare | 10.87B |